XML 17 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Operating expenses:        
Research and development (includes related party amounts of $287, $179, $839 and $653, respectively) $ 10,545 $ 1,990 $ 44,657 $ 5,059
General and administrative (includes related party amounts of $0, $107, $116 and $328, respectively) 2,242 245 4,664 551
Total operating expenses 12,787 2,235 49,321 5,610
Loss from operations (12,787) (2,235) (49,321) (5,610)
Other (income) expense:        
Other (income) expense (13) 1 31 1
Interest expense - related party   94 99 205
Change in fair value of notes and derivative - related party   4,825 11,051 5,656
Change in fair value of Series A tranche liability     5,476  
Total other (income) expense (13) 4,920 16,657 5,862
Net loss (12,774) (7,155) (65,978) (11,472)
Deemed dividend     (1,552)  
Net loss attributable to common shareholders (12,774) (7,155) (67,530) (11,472)
Net loss (12,774) (7,155) (65,978) (11,472)
Unrealized gain (loss) on investment securities 6   6  
Foreign currency translation 23   11  
Comprehensive loss $ (12,745) $ (7,155) $ (65,961) $ (11,472)
Net loss per share attributable to common shareholders, basic and diluted $ (3.17) $ (3.58) $ (19.81) $ (5.82)
Shares used to compute basic and diluted net loss per share attributable to common shareholders 4,026,083 1,998,548 3,409,036 1,971,081